This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Bacillus anthracis Antigen
Product Overview
BioVenic's Recombinant Bacillus anthracis Antigen is a recombinant antigen produced by E.coli. This antigen has undergone a rigorous purification process. It can be used for ELISA plate coating or for the preparation of enzyme conjugates.
Specifications
Target Information
Bacillus anthracis is a large, Gram-positive, rod-shaped, spore-forming, facultative anaerobic bacterium that serves as the causative agent of anthrax, a severe zoonotic disease affecting domestic and wild herbivores, as well as humans. It is a Tier 1 select agent due to its historical and potential use as a biological weapon. The organism alternates between a dormant, highly resilient endospore form that survives for decades in soil, and a vegetative form that replicates rapidly within a host. Key targets for diagnostics, therapeutics (such as monoclonal antibodies), and vaccine formulation include the Poly-D-glutamic acid capsule (which inhibits phagocytosis) and the tripartite anthrax toxin complex, which consists of three distinct plasmid-encoded proteins: Protective Antigen (PA), Edema Factor (EF), and Lethal Factor (LF).
Shipping and Storage
This product is shipped with gel ice bags. Store at 0-4°C for no more than 2 weeks, or -20°C or below for long-term storage.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
